2014 rsna outstanding researcher

1
COMMUNICATIONS n SPECIAL COMMUNICATIONS Radiology: Volume 273: Number 2—November 2014 n radiology.rsna.org 317 T heodore S. Lawrence, MD, PhD, has established himself as a world- renowned researcher for his pio- neering use of radiation for the treatment of intrahepatic cancers. In particular, he led a team that developed a model that predicts the maximum safe dose of radia- tion that can be given to liver tumors, and showed that these higher doses could cure some previously incurable cancers. More recently Dr Lawrence has been working with radiologists to develop new methods of imaging and then targeting resistant portions of liver tumors and avoiding sensitive regions of the normal liver. He also has led laboratory studies to optimize the use of chemotherapeutic ra- diosensitizers. His preclinical and clinical work established the combination gem- citabine and radiation as a standard ther- apy for pancreatic cancer. He is now fo- cused on combining molecularly targeted radiation sensitizers with chemotherapy and radiation therapy. Dr Lawrence is the chair of the De- partment of Radiation Oncology and the Isadore Lampe Professor of Radiation Oncology at the University of Michigan (Ann Arbor, Mich) and co-chair of the N. Reed Dunnick, MD 2014 RSNA Outstanding Researcher 1 Radiation Sciences Program of the Uni- versity of Michigan Comprehensive Can- cer Center. He is president of the Radia- tion Oncology Institute and of the Society of Chairs of Radiation Oncology. Dr Lawrence joined the faculty of the University of Michigan in 1987, following a fellowship in medical oncology and a residency in radiation oncology at the Na- tional Cancer Institute. He received his research degree in cell biology from the Rockefeller University (New York, NY), followed by his medical degree from Cor- nell University (New York, NY) and an internal medicine residency at Stanford University (Stanford, Calif). Dr Lawrence is a member of the Board of Scientific Advisors of the Na- tional Cancer Institute and a member of the Institute of Medicine of the National Academy of Science. He is an editor of Translational Oncology and The Cancer Journal, a senior editor of Cancer Re- search, and an associate editor of Semi- nars in Radiation Oncology. He also served as associate editor at the Journal of the National Cancer Institute, Radia- tion Oncology Investigations, Radiation Research, Cancer Therapeutics, and the Journal of Clinical Oncology. In addition to the United States, Dr Lawrence has lectured in 10 countries on three continents (Asia, Australia, Eu- rope). He presented the Annual Oration in Radiation Oncology, “Looking Beyond Anatomic-based Treatment in Radiation Oncology,” at RSNA 2006. Dr Lawrence, who has served on numerous interna- tional, national, and university commit- tees has authored 267 studies appearing in peer-reviewed journals and 31 book chapters during his illustrious career. Dr Lawrence is past-president of the American Society of Radiation Oncology (ASTRO), former chair of the National Cancer Institute Board of Scientific Coun- cilors, and a member of the Board of Di- rectors of the American Society of Clini- cal Oncology (ASCO). He has been honored with the ASTRO gold medal and an ASCO statesman award. RSNA is pleased to add Outstanding Researcher to Dr Lawrence’s accolades. Published online 10.1148/radiol.14144035 Radiology 2014; 273:317 1 From the Radiological Society of North America, 820 Jo- rie Blvd, Oak Brook, IL 60523. Address correspondence to Marian Strassner (e-mail: [email protected]). q RSNA, 2014 Theodore S. Lawrence, MD, PhD Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights.

Upload: n-reed

Post on 31-Mar-2017

216 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: 2014 RSNA Outstanding Researcher

COMM

UNICATIONS n SPECIAL COM

MUNICATIONS

Radiology: Volume 273: Number 2—November 2014 n radiology.rsna.org 317

Theodore S. Lawrence, MD, PhD, has established himself as a world-renowned researcher for his pio-

neering use of radiation for the treatment of intrahepatic cancers. In particular, he led a team that developed a model that predicts the maximum safe dose of radia-tion that can be given to liver tumors, and showed that these higher doses could cure some previously incurable cancers.

More recently Dr Lawrence has been working with radiologists to develop new methods of imaging and then targeting resistant portions of liver tumors and avoiding sensitive regions of the normal liver. He also has led laboratory studies to optimize the use of chemotherapeutic ra-diosensitizers. His preclinical and clinical work established the combination gem-citabine and radiation as a standard ther-apy for pancreatic cancer. He is now fo-cused on combining molecularly targeted radiation sensitizers with chemotherapy and radiation therapy.

Dr Lawrence is the chair of the De-partment of Radiation Oncology and the Isadore Lampe Professor of Radiation Oncology at the University of Michigan (Ann Arbor, Mich) and co-chair of the

N. Reed Dunnick, MD

2014 RSNA Outstanding

Researcher1

Radiation Sciences Program of the Uni-versity of Michigan Comprehensive Can-cer Center. He is president of the Radia-tion Oncology Institute and of the Society of Chairs of Radiation Oncology.

Dr Lawrence joined the faculty of the University of Michigan in 1987, following a fellowship in medical oncology and a residency in radiation oncology at the Na-tional Cancer Institute. He received his research degree in cell biology from the Rockefeller University (New York, NY), followed by his medical degree from Cor-nell University (New York, NY) and an internal medicine residency at Stanford University (Stanford, Calif).

Dr Lawrence is a member of the Board of Scientific Advisors of the Na-tional Cancer Institute and a member of the Institute of Medicine of the National Academy of Science. He is an editor of Translational Oncology and The Cancer Journal, a senior editor of Cancer Re-search, and an associate editor of Semi-nars in Radiation Oncology. He also served as associate editor at the Journal of the National Cancer Institute, Radia-tion Oncology Investigations, Radiation Research, Cancer Therapeutics, and the Journal of Clinical Oncology.

In addition to the United States, Dr Lawrence has lectured in 10 countries on three continents (Asia, Australia, Eu-rope). He presented the Annual Oration in Radiation Oncology, “Looking Beyond Anatomic-based Treatment in Radiation Oncology,” at RSNA 2006. Dr Lawrence, who has served on numerous interna-tional, national, and university commit-tees has authored 267 studies appearing in peer-reviewed journals and 31 book chapters during his illustrious career.

Dr Lawrence is past-president of the American Society of Radiation Oncology (ASTRO), former chair of the National Cancer Institute Board of Scientific Coun-cilors, and a member of the Board of Di-rectors of the American Society of Clini-cal Oncology (ASCO). He has been honored with the ASTRO gold medal and an ASCO statesman award. RSNA is pleased to add Outstanding Researcher to Dr Lawrence’s accolades.

Published online10.1148/radiol.14144035

Radiology 2014; 273:317

1From the Radiological Society of North America, 820 Jo-rie Blvd, Oak Brook, IL 60523. Address correspondence to Marian Strassner (e-mail: [email protected]).

q RSNA, 2014 Theodore S. Lawrence, MD, PhD

Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights.